Evidence map›Paper›PMID 39645626›Full record

ArticleArchives of virology2024

Molecular and ultrastructural characteristics of virulent and attenuated vaccine strains of goose parvovirus LIV-22.

Ezekiel S Oloruntimehin, Sofya I Volodina, Ivan V Patraman, Grigory A Nadtochey, Alexander S Malogolovkin

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ezekiel S OloruntimehinMolecular Virology Laboratory, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Trubetskaya 8, 119048, Moscow, Russia.
Sofya I VolodinaMolecular Virology Laboratory, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Trubetskaya 8, 119048, Moscow, Russia.
Ivan V PatramanMolecular Virology Laboratory, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Trubetskaya 8, 119048, Moscow, Russia.
Grigory A NadtocheyFederal Research Center - All-Russian Research Institute of Experimental Veterinary Medicine named after K.I. Skrjabin and Y. R. Kovalenko of the Russian Academy of Sciences, Ryazanskiy pr. 24/1, 109428, Moscow, Russia.
Alexander S MalogolovkinMolecular Virology Laboratory, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), Trubetskaya 8, 119048, Moscow, Russia. Malogolovkin_a_s@staff.sechenov.ru.ORCID http://orcid.org/0000-0003-1352-1780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disease caused by goose parvovirus (GPV) affects young goslings and ducks and leads to substantial losses for farmers due to high mortality rates, reaching 70-100% in naive flocks. Here, we present the results of a study focusing on the historical virulent GPV LIV-22 strain, which was isolated in the USSR in 1972. An attenuated GPV LIV-22 vaccine strain that was generated by continuous passaging in goose embryonic fibroblasts was also studied. Phylogenetic analysis placed both GPV LIV-22 strains in the classical GPV group, close to the vaccine and low-pathogenic strains. However, several individual changes in the GPV LIV-22 VP1 gene highlight the uniqueness of the evolution and adaptation mechanism of GPV LIV-22 strains. Transmission electron microscopy (TEM) revealed severe ultrastructural changes in goose hepatocytes and enterocytes as early as 24-48 h postinfection, confirming abrupt GPV pathogenesis. This description of some of the essential characteristics of the GPV LIV-22 virulent and vaccine strain will be useful for studying GPV evolution and molecular pathogenesis.

Indexed as

GeeseParvoviridae InfectionsPhylogenyPoultry DiseasesVaccines, AttenuatedViral VaccinesAnimalsCapsid ProteinsDucksMicroscopy, Electron, TransmissionParvovirinaeVirulenceCapsid ProteinsVaccines, AttenuatedViral Vaccines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.